Evidence map›Paper›PMID 41315958›Full record

ArticleBMC gastroenterology2025

Postoperative early recurrence prediction of pancreatic cancer based on CT and pathomics.

Wei Cao, Jing-Yu Li, Min Wang, Wu-Yang Zhang, Bin Wang, Dan Shi, Meng-Ru Li, Wei Wei

Abstract read
In one paragraph

Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wei CaoDepartment of Radiology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Sciences and Technology of China, No.17 Lujiang Road, HeFei, Anhui, 230001, China.
Jing-Yu LiDepartment of Radiology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Sciences and Technology of China, No.17 Lujiang Road, HeFei, Anhui, 230001, China.
Min WangDepartment of Radiology, Wannan Medical College, Anhui Provincial Hospital, Hefei, Anhui, 230001, China.
Wu-Yang ZhangGraduate Department, Bengbu Medical University, Bengbu, Anhui, China.
Bin WangGraduate Department, Bengbu Medical University, Bengbu, Anhui, China.
Dan ShiDepartment of Radiology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Sciences and Technology of China, No.17 Lujiang Road, HeFei, Anhui, 230001, China.
Meng-Ru LiDepartment of Radiology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Sciences and Technology of China, No.17 Lujiang Road, HeFei, Anhui, 230001, China.
Wei WeiDepartment of Radiology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Sciences and Technology of China, No.17 Lujiang Road, HeFei, Anhui, 230001, China. weiweill@ustc.edu.cn.

Funding

Joint Fund for Medical Artificial Intelligence of USTC MAI2023C006Level A Funding Project for Reserve Candidates of Academic and Technical Leaders in Anhui Province 2022H279the National Natural Science Foundation of China 82271991
6 · The paper itself

Abstract

backgroundPancreatic cancer (PC) is one of the most aggressive malignancies, with a poor prognosis and a high rate of postoperative recurrence. Patients with early recurrence typically do not benefit from surgery. Therefore, identifying high-risk patients for early tumor recurrence before surgery is critical for developing personalized treatment strategies. This study is to investigate the clinical value of a multi-scale model, constructed using CT and pathological images, in predicting early recurrence risk following curative surgery for pancreatic cancer.

methodsA total of 121 patients with pancreatic ductal adenocarcinoma (PDAC) who underwent radical surgery at our hospital between February 2018 and October 2022 were included in this study. A retrospective analysis was conducted on the clinical, CT imaging, and histopathological data of all patients, with follow-up until December 2023. Based on clinical factors, radiomics features, and pathomics features, we developed clinical, radiomics, pathomics, and integrated model. A nomogram was generated to visually analyze the integrated model. The optimal cutoff values were determined using X-tile software, and all patients were stratified into high-risk and low-risk groups. Kaplan-Meier survival curves were plotted, and Log-rank tests were performed to assess the significance of survival differences between the groups. The predictive performance of the four models was evaluated using the concordance index (C-index).

resultsMultivariate Cox regression analyses identified postoperative CA19-9 levels and perineural invasion as independent predictors of early recurrence. The integrated model demonstrated superior predictive performance compared to other individual models, with C-index values of 0.752 (95% CI: 0.681–0.814) in the training cohort and 0.740 (95% CI: 0.680–0.793) in the validation cohort.

conclusionThe multi-scale integrated model incorporating clinical parameters, radiomics features, and pathomics signatures demonstrates superior predictive accuracy for early recurrence in pancreatic cancer patients, enabling precise risk stratification and supporting personalized adjuvant treatment planning. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Carcinoma, Pancreatic DuctalNeoplasm Recurrence, LocalPancreatic NeoplasmsAgedFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNomogramsPredictive Value of TestsPrognosisRadiomicsRetrospective StudiesTomography, X-Ray ComputedEarly recurrencePancreatic ductal adenocarcinomaPathomicsRadiomics

Identifiers

PMID41315958
PMCPMC12752170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.